本页面由Tiger Trade Technology Pte. Ltd.提供服务

ANI Pharmaceuticals, Inc.

77.62
+3.414.59%
成交量:35.30万
成交额:2,697.25万
市值:17.44亿
市盈率:23.35
高:78.33
开:73.97
低:73.38
收:74.21
52周最高:99.50
52周最低:56.71
股本:2,246.90万
流通股本:2,038.01万
量比:1.44
换手率:1.73%
股息:- -
股息率:- -
每股收益(TTM):3.32
每股收益(LYR):3.32
净资产收益率:16.16%
总资产收益率:3.82%
市净率:3.23
市盈率(LYR):23.38

数据加载中...

2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities